Search Within

Ellen Marlese Basu

  1. "General Oncology Service"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (17)
  2. GSK Faculty (17)
  3. General Oncology Service (17)
  4. Neuroblastoma Service (17)
  5. Pediatrics, Department of (17)
  6. Tow Center for Developmental Oncology (TCDO) (17)

More Groups

People
  1. Nai-Kong Cheung (17)
  2. Shakeel Modak (17)
  3. Brian Kushner (16)
  4. Stephen Roberts (15)
  5. Irene Cheung (12)
  6. Audrey Mauguen (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Cancer Research (2)
  2. JAMA Oncology (2)
  3. Journal of Clinical Oncology (2)
  4. OncoImmunology (2)
  5. Oncotarget (2)
  6. Pediatric Blood and Cancer (2)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Medical Association (2)
  3. American Society of Clinical Oncology (2)
  4. Impact Journals (2)
  5. Landes Bioscience (2)
  6. Wiley Periodicals, Inc (2)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Ovarian function in female survivors of high-risk neuroblastoma
    Journal Article

    Jimenez-Kurlander, L.; DeRosa, A.; Kostrzewa, C. E.; Moskowitz, C. S.; Bogardus, K.; Antal, Z.; Wolden, S.; La Quaglia, M. P.; Basu, E. M.; Cardenas, F. I.; more...
    Pediatric Blood and Cancer (2024)

    Fulltext@MSK | Save
  • Long prime-boost interval and heightened anti-GD2 antibody response to carbohydrate cancer vaccine
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Basu, E. M.; Feng, Y.; Kushner, B. H.; Cheung, N. K.
    Vaccines (2024)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Plasma cell-free DNA analysis uncovered tumor heterogeneity and clonal evolution during treatment for relapsed neuroblastoma
    Meeting Abstract

    Cardenas, F. I.; Kothari, P.; Tsui, D.; Basu, E.; Roberts, S.; Cheung, N. K.; Kushner, B.; Modak, S.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial
    Journal Article

    Kushner, B. H.; Cheung, I. Y.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K.
    JAMA Oncology (2018)

    Fulltext@MSK | Save